JEFFREY KISER: Open Payments
NPI 1902918485 · MONROE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 13 payments from 7 companies in 2025. Trend: 2023 $34 · 2024 $108 · 2025 $332
Food & beverage: $241Education: $91
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $130 |
| ABBVIE INC. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
Products named: VRAYLAR, ABILIFY MAINTENA, SPRAVATO, AUSTEDO XR, ARISTADA, CAPLYTA, UZEDY, INGREZZA.
Industry payments across NC — which companies pay providers there.
